Topics
Glioblastoma | Treatment | Targeted therapy | Senicapoc
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Senicapoc
Eschen JT, Jensen LL, Hausmann D,
Lind ANR, Lukacova S, Weischenfeldt J, Lassen U, Westphal M,
Winkler F, Simonsen U, Korshoej AR.
SENIPERA
Phase 0/1 randomized window-of-opportunity clinical trial of
SENIcapoc and PERAmpanel mono- and combination therapy of newly
diagnosed glioblastoma: a trial protocol.
BMC
Cancer. 2026 Apr
14;26(1):667. doi:
10.1186/s12885-026-15784-y. PMID:
41981510. Trial
registration ID:
EU-CT: 2025–522605-37–00.
ˍ